drugset
Drugs / sD-NP-GT8 DNA
last change Apr 2025 re-read 2 minutes ago

sD-NP-GT8 DNA

Vaccine

Developed for
HIV infectious disease
Investigated by
Access to Advanced Health Institute (AAHI) · Department of Health and Human Services · HIV Vaccine Trials Network · Inovio Pharmaceuticals · National Institute of Allergy and Infectious Diseases (NIAID) · The Betty and Dale Bumpers Vaccine Research Center (VRC)
+1 more · The Wistar Institute

Trials 1 · a red edge is where a trial was stopped

today NCT05781542 · Ph 1
202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT05781542 Apr 2023 → Oct 2024 HIV infectious disease National Institute of Allergy and Infectious Diseases (NIAID) Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as sD-NP-GT8 DNA ClinicalTrials.gov intervention name — accepted as the source's own label NCT05781542 ↗
Modality Vaccine “recombinant DNA vaccine” NCT05781542 ↗